Milbeguard Duo 2.5 mg / 25 mg chewable tablets for small dogs and puppies

Држава: Ирска

Језик: Енглески

Извор: HPRA (Health Products Regulatory Authority)

Активни састојак:

Milbemycin oxime; Praziquantel

Доступно од:

Ceva Santé Animale

АТЦ код:

QP54AB51

INN (Међународно име):

Milbemycin oxime; Praziquantel

Фармацеутски облик:

Chewable tablet

Тип рецептора:

POM: Prescription Only Medicine as defined in relevant national legislation

Терапеутска област:

milbemycin oxime, combinations

Датум одобрења:

2024-01-19

Карактеристике производа

1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Milbeguard Duo 2.5 mg / 25 mg chewable tablets for small dogs and
puppies
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCES:
Milbemycin oxime
2.5 mg
Praziquantel
25 mg
EXCIPIENTS:
QUALITATIVE
COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
Povidone
Croscarmellose sodium
Lactose monohydrate
Chicken flavour*
Yeast
Cellulose microcrystalline
Silica, colloidal anhydrous
Magnesium stearate
_*Artificial origin_
Oblong tablet, beige to light brown, scored on one side. The tablet
can be divided into two equal parts.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Dogs weighing at least 0.5 kg
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
In dogs: treatment of mixed infections by adult cestodes and nematodes
of the following species:
- Cestodes:
_Dipylidium caninum _
_Taenia _
spp
_. _
_Echinococcus _
spp
_. _
_Mesocestoides _
spp
_. _
- Nematodes:
_Ancylostoma caninum _
_Toxocara canis _
_Toxascaris leonina _
_Trichuris vulpis _
_Crenosoma vulpis_
(Reduction of the level of infection)
2
_Angiostrongylus vasorum _
(Reduction of the level of infection by immature adult (L5) and adult
parasite
stages; see specific treatment and prevention disease schedules under
section 3.9 “Administration routes
and dosage”)
_Thelazia callipaeda _
(see specific treatment schedule under section 3.9 “Administration
routes and
dosage”)
The product can also be used in the prevention of heartworm disease (
_Dirofilaria immitis_
) if
concomitant treatment against cestodes is indicated.
3.3
CONTRAINDICATIONS
Do not use in puppies of less than 2 weeks of age and/or weighing less
than 0.5 kg.
Do not use in cases of hypersensitivity to the active substances or to
any of the excipients.
See also section 3.5 "Special precautions for use".
3.4
SPECIAL WARNINGS
It is recommended to treat all the animals living in the same
household concomitantly. When infection
with the cestode
_D. caninum _
has been confirmed, concomitant treatment against intermediate hosts,
such
as